Evidence map›Paper›PMID 32628693›Full record

ArticlePloS one2020

Real-time monitoring of oncolytic VSV properties in a novel in vitro microphysiological system containing 3D multicellular tumor spheroids.

Kyoung Jin Lee, Sang Woo Lee, Ha-Na Woo, Hae Mi Cho, Dae Bong Yu, Soo Yeon Jeong, Chul Hyun Joo, Gi Seok Jeong, Heuiran Lee

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kyoung Jin LeeDepartment of Microbiology, University of Ulsan College of Medicine, Seoul, Korea.
Sang Woo LeeBiomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.ORCID 0000-0001-9913-0638
Ha-Na WooDepartment of Microbiology, University of Ulsan College of Medicine, Seoul, Korea.
Hae Mi ChoDepartment of Microbiology, University of Ulsan College of Medicine, Seoul, Korea.
Dae Bong YuDepartment of Microbiology, University of Ulsan College of Medicine, Seoul, Korea.
Soo Yeon JeongBiomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
Chul Hyun JooDepartment of Microbiology, University of Ulsan College of Medicine, Seoul, Korea.
Gi Seok JeongBiomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
Heuiran LeeDepartment of Microbiology, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0002-4241-5664
Ulsan College · KRAsan Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a new class of cancer therapeutic agents, oncolytic viruses (OVs) have gained much attention not only due to their ability to selectively replicate in and lyse tumor cells, but also for their potential to stimulate antitumor immune responses. As a result, there is an increasing need for in vitro modeling systems capable of recapitulating the 3D physiological tumor microenvironment. Here, we investigated the potential of our recently developed microphysiological system (MPS), featuring a vessel-like channel to reflect the in vivo tumor microenvironment and serving as culture spaces for 3D multicellular tumor spheroids (MCTSs). The MCTSs consist of cancer A549 cells, stromal MRC5 cells, endothelial HUVECs, as well as the extracellular matrix. 3D MCTSs residing in the MPS were infected with oncolytic VSV expressing GFP (oVSV-GFP). Post-infection, GFP signal intensity increased only in A549 cells of the MPS. On the other hand, HUVECs were susceptible to virus infection under 2D culture and IFN-β secretion was quite delayed in HUVECs. These results thus demonstrate that OV antitumoral characteristics can be readily monitored in the MPS and that its behavior therein somewhat differs compared to its activity in 2D system. In conclusion, we present the first application of the MPS, an in vitro model that was developed to better reflect in vivo conditions. Its various advantages suggest the 3D MCTS-integrated MPS can serve as a first line monitoring system to validate oncolytic virus efficacy.

Indexed as

Oncolytic VirotherapyA549 CellsCell Culture TechniquesDrug Screening Assays, AntitumorExtracellular MatrixHumansHuman Umbilical Vein Endothelial CellsNeoplasmsOncolytic VirusesSpheroids, CellularVesiculovirus

Identifiers

PMID32628693
PMCPMC7337297
OpenAlexW3038848016

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.